Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
Along with the layoffs, the reshuffle includes prioritisation of pipeline assets with the “highest probability of success.”
Healthcare
FDA halts uniQure’s plans for Huntington’s disease gene therapy
Sensei to ditch its lead candidate and cut workforce amidst strategic review
FDA gives first approval for recurrent respiratory papillomatosis therapy
Sartorius to invest $3m for minority share in biotech start-up Nanotein
African countries plan shift to healthcare funding autonomy amid aid cuts
Can rare disease research in the US thrive under the new administration?
Ultragenyx receives complete response letter for UX111 BLA
